West Allis, Wis. (PRWEB) April 08, 2015
Association for the Bladder Exstrophy Community (A-BE-C) today announced that Dr. Heiko Reutter, a researcher involved in the recent discovery of a gene associated with bladder exstrophy, will speak about the breakthrough and answer questions at a live webinar on Monday, April 13, at 6 p.m. EDT. The complimentary event is beneficial to bladder exstrophy patients, their families and health care professionals. Registration is now open at http://www.bladderexstrophy.com/?p=790.
“This discovery is a significant breakthrough and it raises important questions from patients affected by bladder exstrophy and professionals who treat them,” said Pamela Block, executive director of A-BE-C. “We are fortunate to be among the first to make Dr. Reutter’s knowledge and insights about the research accessible and look forward to exploring with him the details and impact of the study.”
Many members of A-BE-C contributed blood samples that were among the 210 studied in the research. The research report, Genome-wide association study and meta-analysis identify ISL1 as genome-wide significant susceptibility gene for bladder exstrophy, is published in the current online edition of PLOS Genetics. http://dx.doi.org/10.1371/journal.pgen.1005024
Approximately 1 out of 20,000 newborns worldwide is affected by bladder exstrophy, which is considered one of the most severe forms of congenital disorders of the urinary system. Before the results of this study were released the genetic causes of this condition were unknown.
About Association for the Bladder Exstrophy Community (A-BE-C)
A-BE-C is dedicated to supporting people who are affected by bladder exstrophy worldwide. Founded in 1995, the organization works to ensure all who live with this rare and life-altering condition have the opportunity to realize their greatest purpose and potential. Funding for the 501(c)(3) nonprofit’s work comes from contributions from members, individual and corporate donors, and sponsors. http://www.bladderexstrophy.com